187 related articles for article (PubMed ID: 17286966)
21. Bradykinin-induced neuropeptide Y release by human pheochromocytoma tissue.
Eurin J; Barthélemy C; Masson F; Soualmia H; Sarfati E; Carayon A
Neuropeptides; 2002 Aug; 36(4):257-62. PubMed ID: 12372699
[TBL] [Abstract][Full Text] [Related]
22. Autoinhibition of transmitter release from PC12 cells and sympathetic neurons through a P2Y receptor-mediated inhibition of voltage-gated Ca2+ channels.
Lechner SG; Dorostkar MM; Mayer M; Edelbauer H; Pankevych H; Boehm S
Eur J Neurosci; 2004 Dec; 20(11):2917-28. PubMed ID: 15579146
[TBL] [Abstract][Full Text] [Related]
23. Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism.
Hackenthal E; Aktories K; Jakobs KH; Lang RE
Am J Physiol; 1987 Mar; 252(3 Pt 2):F543-50. PubMed ID: 3548437
[TBL] [Abstract][Full Text] [Related]
24. Dopamine inhibits basal prolactin release in pituitary lactotrophs through pertussis toxin-sensitive and -insensitive signaling pathways.
Gonzalez-Iglesias AE; Murano T; Li S; Tomić M; Stojilkovic SS
Endocrinology; 2008 Apr; 149(4):1470-9. PubMed ID: 18096663
[TBL] [Abstract][Full Text] [Related]
25. Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors.
Chen X; DiMaggio DA; Han SP; Westfall TC
Am J Physiol; 1997 Oct; 273(4):H1737-44. PubMed ID: 9362238
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the T-type Ca2+ current by the dopamine D1 receptor in rat adrenal glomerulosa cells: requirement of the combined action of the G betagamma protein subunit and cyclic adenosine 3',5'-monophosphate.
Drolet P; Bilodeau L; Chorvatova A; Laflamme L; Gallo-Payet N; Payet MD
Mol Endocrinol; 1997 Apr; 11(4):503-14. PubMed ID: 9092802
[TBL] [Abstract][Full Text] [Related]
27. Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release.
Okada M; Nutt DJ; Murakami T; Zhu G; Kamata A; Kawata Y; Kaneko S
J Neurosci; 2001 Jan; 21(2):628-40. PubMed ID: 11160442
[TBL] [Abstract][Full Text] [Related]
28. Dopaminergic regulation of dopamine release from PC12 cells via a pertussis toxin-sensitive G protein.
Courtney ND; Howlett AC; Westfall TC
Neurosci Lett; 1991 Jan; 122(2):261-4. PubMed ID: 1827517
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II regulation of renal dopamine uptake and Na(+),K(+)-ATPase activity.
Choi MR; Medici C; Gironacci MM; Correa AH; Fernández BE
Nephron Physiol; 2009; 111(4):p53-8. PubMed ID: 19293600
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of [Ca2+]i transients in rat adrenal chromaffin cells by neuropeptide Y: role for a cGMP-dependent protein kinase-activated K+ conductance.
Lemos VS; Bucher B; Côrtes SF; Takeda K
Eur J Neurosci; 1997 Jun; 9(6):1144-52. PubMed ID: 9215697
[TBL] [Abstract][Full Text] [Related]
31. Dopamine stimulates 45Ca2+ uptake through cAMP, PLC/PKC, and MAPKs in renal proximal tubule cells.
Han JY; Heo JS; Lee YJ; Lee JH; Taub M; Han HJ
J Cell Physiol; 2007 May; 211(2):486-94. PubMed ID: 17167784
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of the neuropeptide Y gene by nerve growth factor: antagonism by glucocorticoids and potentiation by adenosine 3',5'-monophosphate and phorbol ester.
Sabol SL; Higuchi H
Mol Endocrinol; 1990 Mar; 4(3):384-92. PubMed ID: 2160601
[TBL] [Abstract][Full Text] [Related]
33. Gialpha3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event.
Pedrosa R; Gomes P; Hopfer U; Jose PA; Soares-da-Silva P
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1059-66. PubMed ID: 15265766
[TBL] [Abstract][Full Text] [Related]
34. Non-genomic modulation of dopamine release by bisphenol-A in PC12 cells.
Yoneda T; Hiroi T; Osada M; Asada A; Funae Y
J Neurochem; 2003 Dec; 87(6):1499-508. PubMed ID: 14713305
[TBL] [Abstract][Full Text] [Related]
35. mGluR7 inhibits glutamate release through a PKC-independent decrease in the activity of P/Q-type Ca2+ channels and by diminishing cAMP in hippocampal nerve terminals.
Martín R; Torres M; Sánchez-Prieto J
Eur J Neurosci; 2007 Jul; 26(2):312-22. PubMed ID: 17650109
[TBL] [Abstract][Full Text] [Related]
36. 5-HT
Lu CW; Lin TY; Huang SK; Wang SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():122-130. PubMed ID: 29803926
[TBL] [Abstract][Full Text] [Related]
37. Dopamine D(1) receptor facilitation of depolarization-induced release of gamma-amino-butyric acid in rat striatum is mediated by the cAMP/PKA pathway and involves P/Q-type calcium channels.
Arias-Montaño JA; Floran B; Floran L; Aceves J; Young JM
Synapse; 2007 May; 61(5):310-9. PubMed ID: 17318879
[TBL] [Abstract][Full Text] [Related]
38. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C.
Derbez AE; Mody RM; Werling LL
J Pharmacol Exp Ther; 2002 Apr; 301(1):306-14. PubMed ID: 11907188
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activity. Structure-function studies.
Sheriff S; Balasubramaniam A
J Biol Chem; 1992 Mar; 267(7):4680-5. PubMed ID: 1537851
[TBL] [Abstract][Full Text] [Related]
40. Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism.
Park YH; Kantor L; Guptaroy B; Zhang M; Wang KK; Gnegy ME
J Neurochem; 2003 Dec; 87(6):1546-57. PubMed ID: 14713310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
